1. To understand the role of interstitial laser ablations for the treatment of cerebral metastasis
  2. To evaluate the physiological and pharmacokinetic changes induced by interstitial treatment
  3. To assess the validity of open surgery versus radiosurgery versus laser ablation in the treatment of cerebral metastasis
Session date: 
08/06/2018 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Peter C. Warnke, MD, FRCS